Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ventana Growth Funds appears to have been an early-stage venture capital and private equity investment firm rather than an operating biotech or pharma company. Historical sources describe the firm as part of the broader Ventana organization founded by Thomas Gephart in 1974, with activity spanning technology, medical technology, biotechnology, and healthcare investments. The firm reportedly managed domestic and international funds and invested across seed through later-stage financings, including buyout and mezzanine rounds. Publicly available evidence suggests Ventana Growth Funds was an investment manager/adviser with a healthcare and biotech investing practice, not a developer of therapeutic products. The entity does not appear to have a current active operating presence as a standalone life sciences company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ventana Growth Funds.